GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair

被引:30
作者
Wiehe, J. M. [1 ]
Kaya, Z. [2 ]
Homann, J. M. [1 ]
Woehrle, J. [1 ]
Vogt, K. [1 ]
Nguyen, T. [1 ]
Rottbauer, W. [1 ]
Torzewski, J. [3 ]
Fekete, N. [5 ]
Rojewski, M. [5 ]
Schrezenmeier, H. [5 ]
Moepps, B. [4 ]
Zimmermann, O. [1 ,3 ]
机构
[1] Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany
[2] Heidelberg Univ, Dept Internal Med 3, D-69120 Heidelberg, Germany
[3] Cardiovasc Ctr Oberallgau Kempten, D-87509 Immenstadt, Germany
[4] Univ Ulm, Inst Pharmacol & Toxicol, D-89081 Ulm, Germany
[5] Univ Ulm, DRK Blood Transfus Serv Baden Wurttemberg Hessen, Inst Clin Transfus Med & Immunogenet, D-89081 Ulm, Germany
关键词
Mesenchymal stromal cells; CXCR4; Cell migration; Homing; mRNA-nucleofection; PROGENITOR CELLS; INTRACORONARY TRANSPLANTATION; MYOCARDIAL-INFARCTION; MIGRATION; DELIVERY; THERAPY; RECEPTOR; GENE;
D O I
10.1016/j.ijcard.2012.05.065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Human mesenchymal stem cells (MSC) have been utilized for cardiac regeneration after myocardial damage. Their clinical effects are marginal and only a minority of administered cells could make their way into the myocardium. The chemokine receptor CXCR4 has been identified as crucial for migration and homing of stem cells. In this study we overexpressed CXCR4 on human MSC to improve cell trafficking and tissue repair. Methods: Human MSC were isolated from the spongiosa of tibia and femur as well as from pelvic bone marrow. MSC were characterized by differentiation assays and FACS analysis. CXCR4 was overexpressed by mRNA-nucleofection. Intracellular signaling was analyzed to demonstrate functionality of CXCR4. The modified Boyden chamber, wounding assays and time lapse microscopy were utilized to investigate MSC migration. Results: MSC did not express relevant amounts of CXCR4 spontaneously. CXCR4 could be overexpressed in 93% of MSC with a cell viability of 62%. Functionality of the overexpressed CXCR4 was demonstrated by a significant cytosolic Ca2+ increase and activation of different MAP kinases followed by SDF-1 alpha stimulation. In contrast no improvement of cell migration could be observed. There was a strong basal MSC chemokinesis independent from CXCR4 expression. Conclusions: CXCR4 could be effectively overexpressed in human MSC by mRNA-nucleofection. Despite functionality of CXCR4 MSC were characterized by a strong basal chemokinesis that could not be further enhanced by CXCR4 overexpression. As isolation, culture and nucleofection of pelvic bone marrow-derived MSC basically fulfill the GMP-requirements our approach seems suited for an in vivo application in patients. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:2073 / 2081
页数:9
相关论文
共 33 条
[1]   Transcoronary transplantation of progenitor cells after myocardial infarction [J].
Assmus, Birgit ;
Honold, Joerg ;
Schaechinger, Volker ;
Britten, Martina B. ;
Fischer-Rasokat, Ulrich ;
Lehmann, Ralf ;
Teupe, Claudius ;
Pistorius, Katrin ;
Martin, Hans ;
Abolmaali, Nasreddin D. ;
Tonn, Torsten ;
Dimmeler, Stefanie ;
Zeiher, Andreas M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1222-1232
[2]   Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].
Barbash, IM ;
Chouraqui, P ;
Baron, J ;
Feinberg, MS ;
Etzion, S ;
Tessone, A ;
Miller, L ;
Guetta, E ;
Zipori, D ;
Kedes, LH ;
Kloner, RA ;
Leor, J .
CIRCULATION, 2003, 108 (07) :863-868
[3]  
Boyle AJ, 2010, METHODS MOL BIOL, V660, P65, DOI 10.1007/978-1-60761-705-1_5
[4]   Mesenchymal stem cells as trophic mediators [J].
Caplan, Arnold I. ;
Dennis, James E. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 98 (05) :1076-1084
[5]   Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction [J].
Chen, SL ;
Fang, W ;
Ye, F ;
Liu, YH ;
Qian, J ;
Shan, S ;
Zhang, J ;
Zhao, RCH ;
Liao, LM ;
Lin, S ;
Sun, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01) :92-95
[6]   Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance [J].
Cheng, Zhaokang ;
Ou, Lailiang ;
Zhou, Xin ;
Li, Fei ;
Jia, Xiaohua ;
Zhang, Yinguo ;
Liu, Xiaolei ;
Li, Yuming ;
Ward, Christopher A. ;
Melo, Luis G. ;
Kong, Deling .
MOLECULAR THERAPY, 2008, 16 (03) :571-579
[7]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[8]   A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction [J].
Freyman, T ;
Polin, G ;
Osman, H ;
Crary, J ;
Lu, MM ;
Cheng, L ;
Palasis, M ;
Wilensky, RL .
EUROPEAN HEART JOURNAL, 2006, 27 (09) :1114-1122
[9]   Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? [J].
Gavins, Felicity N. E. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (06) :266-276
[10]   Plasticity of bone marrow-derived stem cells [J].
Grove, JE ;
Bruscia, E ;
Krause, DS .
STEM CELLS, 2004, 22 (04) :487-500